Allogene Therapeutics Announces June 2020 Virtual Investor Conference Participation
SOUTH SAN FRANCISCO, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that management plans to participate in the following June 2020 virtual investor conferences.
Jefferies Virtual Healthcare Conference
Goldman Sachs 41st Annual Global Healthcare Conference
William Blair 40th Annual Growth Stock Conference
Raymond James 2020 Human Healthcare Innovation Conference*
JMP Securities Hematology and Oncology Forum
Webcasts will be made available on the Company's website at www.allogene.com under the Investors tab in the News and Events section (https://ir.allogene.com/events). Following the live audio webcast, a replay will be available on the Company's website for approximately 30 days.
*This event will not be webcast.
About Allogene Therapeutics
Cautionary Note on Forward-Looking Statements for Allogene
AlloCAR T™ is a trademark of Allogene Therapeutics, Inc.
Allogene Media/Investor Contact:
Scaling Use Case
Session Details TBA
Smart City with a Social Conscience